See more : Mithra Pharmaceuticals SA (MITPF) Income Statement Analysis – Financial Results
Complete financial analysis of ACON S2 Acquisition Corp. (STWOU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of ACON S2 Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Till Capital Corporation (TILCF) Income Statement Analysis – Financial Results
- Neolife SA (ALNLF.PA) Income Statement Analysis – Financial Results
- Mineros S.A. (MNSAF) Income Statement Analysis – Financial Results
- VT Co., Ltd. (018290.KQ) Income Statement Analysis – Financial Results
- Borgestad ASA (BOR.OL) Income Statement Analysis – Financial Results
ACON S2 Acquisition Corp. (STWOU)
About ACON S2 Acquisition Corp.
ACON S2 Acquisition Corp. focuses effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded in 2020 and is headquartered in Washington, District of Columbia.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 7.54M | 894.00K | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 20.50M | 2.66M | 572.00K | 436.00K | 0.00 |
Gross Profit | -12.96M | -1.76M | -572.00K | -436.00K | 0.00 |
Gross Profit Ratio | -171.82% | -197.20% | 0.00% | 0.00% | 0.00% |
Research & Development | 42.63M | 71.98M | 30.10M | 12.90M | 6.66M |
General & Administrative | 22.57M | 27.47M | 27.31M | 3.34M | 1.27M |
Selling & Marketing | 7.74M | 6.94M | 3.49M | 1.16M | 908.00K |
SG&A | 30.32M | 34.41M | 30.79M | 4.50M | 3.23M |
Other Expenses | 0.00 | 861.00K | -153.88M | -67.00K | 0.00 |
Operating Expenses | 72.95M | 106.39M | 60.90M | 17.39M | 10.53M |
Cost & Expenses | 93.45M | 106.39M | 60.90M | 17.39M | 10.53M |
Interest Income | 5.26M | 2.19M | 1.89M | 132.00K | 1.02M |
Interest Expense | 0.00 | 2.19M | 1.89M | 132.00K | 0.00 |
Depreciation & Amortization | 6.51M | 2.66M | 572.00K | 436.00K | 260.00K |
EBITDA | -79.39M | -103.97M | -60.03M | -16.96M | -9.63M |
EBITDA Ratio | -1,052.94% | -14,537.70% | 0.00% | 0.00% | 0.00% |
Operating Income | -85.91M | -105.49M | -60.90M | -17.39M | -9.89M |
Operating Income Ratio | -1,139.32% | -11,800.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 8.33M | 27.52M | -416.52M | -13.03M | -1.66M |
Income Before Tax | -77.58M | -77.97M | -477.41M | -30.42M | -11.55M |
Income Before Tax Ratio | -1,028.89% | -8,721.36% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | -27.52M | -152.57M | 65.00K | 0.00 |
Net Income | -77.58M | -77.97M | -324.85M | -30.48M | -11.55M |
Net Income Ratio | -1,028.89% | -8,721.36% | 0.00% | 0.00% | 0.00% |
EPS | -0.48 | -7.66 | -58.53 | -7.77 | -1.64 |
EPS Diluted | -0.48 | -7.66 | -58.53 | -7.77 | -1.64 |
Weighted Avg Shares Out | 159.96M | 10.18M | 5.55M | 3.93M | 7.04M |
Weighted Avg Shares Out (Dil) | 159.96M | 10.18M | 5.55M | 3.93M | 7.04M |
Source: https://incomestatements.info
Category: Stock Reports